SEOUL, South Korea--(BUSINESS WIRE)--Customized medicine & biotechnology company Macrogen Inc. (CEO HyungTae Kim, www.macrogen.com) announced that it has made an agreement to supply the company’s X-Genome (Xpressway to Genome) service, which is a large-scale human genome analysis service, to the Institute of Psychiatry at King’s College London (www.kcl.ac.uk, hereinafter KCL).
Help employers find you! Check out all the jobs and post your resume.